Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Videla

Showing results (41-50 of 81) with videos related to

Pageof 9
Sort By:
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
Clinical ManifestationsLaura Del Hoyo, Katja Sandkühler, Laura Videla, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 18, 2025
Discrepancies in assessing intellectual disability levels in adults with Down syndrome: Implications for dementia diagnosisLaura Del Hoyo Soriano, Katja Sandkühler, Laura Videla, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Alzheimer's Imaging ConsortiumMaria Franquesa-Mullerat, Alejandra O Morcillo-Nieto, José Enrique Arriola-Infante, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 22, 2024
Cortical microinfarcts in adults with Down syndrome assessed with 3T-MRIMateus Rozalem Aranha, Victor Montal, Hilde van den Brink, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 17, 2026
Factors impacting survival in individuals with Down syndrome-associated Alzheimer's diseaseBessy Benejam, Mary McCarron, María Carmona-Iragui, et al.
Nature Communications|November 10, 2025
Plasma p-tau217 as a biomarker of Alzheimer's disease pathology in individuals with Down syndromeHanna Huber, Javier Arranz, Burak Arslan, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|September 19, 2025
Study of brain perfusion in adults with Down syndrome along the Alzheimer's disease continuumMaria Franquesa-Mullerat, Alejandra O Morcillo-Nieto, José Enrique Arriola-Infante, et al.
Nature Communications|July 15, 2021
Phosphorylated tau181 in plasma as a potential biomarker for Alzheimer's disease in adults with Down syndromeAlberto Lleó, Henrik Zetterberg, Jordi Pegueroles, et al.
Research Square|March 27, 2026
Amyloid-linked versus age-driven copathologies in Alzheimer's dementia: differential associations with APOE ε4Íñigo Rodríguez-Baz, Lidia Vaqué-Alcázar, Lucía Maure-Blesa, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 21, 2025
Nerve growth factor precursor alterations in neuron-derived extracellular vesicles from individuals with Down syndrome along the Alzheimer's disease continuumNatalia Valle-Tamayo, Mateus Rozalem Aranha, Rocío Pérez-González, et al.
Pageof 9

Showing results (41-50 of 81) with videos related to

Sort By:
Pageof 9
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
Clinical ManifestationsLaura Del Hoyo, Katja Sandkühler, Laura Videla, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 18, 2025
Discrepancies in assessing intellectual disability levels in adults with Down syndrome: Implications for dementia diagnosisLaura Del Hoyo Soriano, Katja Sandkühler, Laura Videla, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Alzheimer's Imaging ConsortiumMaria Franquesa-Mullerat, Alejandra O Morcillo-Nieto, José Enrique Arriola-Infante, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 22, 2024
Cortical microinfarcts in adults with Down syndrome assessed with 3T-MRIMateus Rozalem Aranha, Victor Montal, Hilde van den Brink, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 17, 2026
Factors impacting survival in individuals with Down syndrome-associated Alzheimer's diseaseBessy Benejam, Mary McCarron, María Carmona-Iragui, et al.
Nature Communications|November 10, 2025
Plasma p-tau217 as a biomarker of Alzheimer's disease pathology in individuals with Down syndromeHanna Huber, Javier Arranz, Burak Arslan, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|September 19, 2025
Study of brain perfusion in adults with Down syndrome along the Alzheimer's disease continuumMaria Franquesa-Mullerat, Alejandra O Morcillo-Nieto, José Enrique Arriola-Infante, et al.
Nature Communications|July 15, 2021
Phosphorylated tau181 in plasma as a potential biomarker for Alzheimer's disease in adults with Down syndromeAlberto Lleó, Henrik Zetterberg, Jordi Pegueroles, et al.
Research Square|March 27, 2026
Amyloid-linked versus age-driven copathologies in Alzheimer's dementia: differential associations with APOE ε4Íñigo Rodríguez-Baz, Lidia Vaqué-Alcázar, Lucía Maure-Blesa, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 21, 2025
Nerve growth factor precursor alterations in neuron-derived extracellular vesicles from individuals with Down syndrome along the Alzheimer's disease continuumNatalia Valle-Tamayo, Mateus Rozalem Aranha, Rocío Pérez-González, et al.
Pageof 9